Table 2.
Intrinsic subtypes | |||||
---|---|---|---|---|---|
Luminal A N (%) | Luminal B HER2pos N (%) | Luminal B HER2neg N (%) | Triple negative N (%) | P | |
Age groups (years) | |||||
≤ 40 | 5 (12) | 1 (20) | 4 (29) | 2 (18.2) | |
41–50 | 8 (18) | 2 (40) | 3 (21) | 3 (27.3) | |
51–60 | 11 (26) | 1 (20) | 2 (14.3) | 1 (9.1) | |
61–70 | 9 (21) | 1 (20) | 2 (14.3) | 1 (9.1) | |
≥ 70 | 10 (23) | 0 (0) | 3 (21.4) | 4 (36.3) | 0.83 |
Pathologic T-stage | |||||
pT1 | 38 (88) | 5 (100) | 11 (79) | 6 (54.5) | |
pT2 | 5 (12) | 0 (0) | 3 (21) | 5 (45.5) | 0.04 |
Nottingham grading system | |||||
NHG 1 | 14 (33) | 0 (0) | 1 (7) | 0 (0) | |
NHG 2 | 23 (53) | 3 (60) | 6 (43) | 3 (27) | |
NHG 3 | 6 (14) | 2 (40) | 7 (50) | 8 (73) | 0.002 |
CD163-expression | |||||
Negative (< 15%) | 37 (86) | 2 (50) | 10 (71) | 8 (73) | |
Positive (≥ 15%) | 6 (14) | 2 (50) | 4 (29) | 3 (27) | 0.25 |
Macrophage infiltration | |||||
Low | 31 (72) | 1 (25) | 3 (21) | 2 (18) | |
Moderate | 10 (23) | 3 (75) | 3 (43) | 5 (46) | |
High | 2 (5) | 0 (0) | 5 (36) | 4 (36) | 0.001 |